Radiolabelled bisphosphonates and method
    6.
    发明授权
    Radiolabelled bisphosphonates and method 失效
    放射性标记的双膦酸盐和方法

    公开(公告)号:US06534488B1

    公开(公告)日:2003-03-18

    申请号:US10031760

    申请日:2002-05-08

    IPC分类号: C07F938

    摘要: The present invention relates to 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in an identical manner, but also deliver a significant radiocytotoxic effect to the surrounding cells. This should result, given the favorable energetics of the &bgr; particle emission from the 33P nuclide, in a loss of proliferative capacity of cells associated with the tumor lesion. The relative stability and in vivo localisation of bisphosphonates makes them good candidates as 32P/33P delivery vehicles.

    摘要翻译: 本发明涉及作为放射治疗放射性药物的32P或33P标记的双膦酸盐。 与未标记试剂化学相同的32P或33P标记的双膦酸盐预期以相同的方式靶向病变部位,但也对周围细胞产生显着的放射性细胞毒性作用。 考虑到来自33P核素的β粒子发射的有利能量,与肿瘤病变相关的细胞的增殖能力丧失将导致这一点。 双膦酸盐的相对稳定性和体内定位使其成为32P / 33P递送载体的良好候选物。